Skip to main content
Oregon.gov Homepage

Monoclonal antibody therapy (mAb)

COVID-19 cases can result in serious illness, hospitalizations and deaths. Monoclonal antibody (mAb) therapies can help prevent severe illness, save lives, and reduce the burden on our hospitals and health systems. This therapy is available through shots or IV infusion, making it easier for providers to give and patients to get. mAb therapies can be used as treatment for confirmed positive patients and as prevention after a COVID-19 exposure.

Weekly federal allocations and provider requests
Due to limitations in supply, Oregon Health Authority (OHA) is working to equitably distribute our federal allocation, which is updated weekly.

Sites receiving mAb therapy
Sites listed below are those receiving shipments of mAb therapies in the most recent week. Sites may redistribute their allocation to other providers. This list is not indicative of how much product a location may have available at any given time. If you are seeking mAb therapy for yourself, please contact your provider.


Notes:

Allocations are prioritized to ordering sites weekly, based on the following considerations:

  • Federally Qualified Health Centers & Tribal Health Clinics, which serve communities disproportionately impacted by COVID-19
  • County-level COVID-19 hospitalizations & cases 
  • Sites located in communities disproportionately impacted by COVID-19 (utilizing COVID-19 Community Vulnerability Index)
  • Site-level weekly utilization rate

Download the list


Ordering link for registered providers

Healthcare provider resources

Weekly online meetings

Please email COVID19Therapeutics@hhs.gov to request Zoom links for these calls ​

Weekly Federal COVID 19 Response: Monoclonal Antibodies 101 Webinar

  • Fridays 9-10 am P​T (Every other Friday)
  • Target audience: new administration sites and health officials

CDC Federal COVID 19 Response: Monoclonal Antibodies Office hours

  • Tuesdays and Thursdays 11 am-noon PT
HHS Therapeutics Distribution Locations​ Operational playbook

Monoclonal Antibody product information ​​

Casirivimab/Imdevimab

Bamlanivimab/Etesivimab

Sotrovimab

More resources for providers


Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how

×